Baolingbao Biology Co.,Ltd.
002286.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.22B
Close$
$2.57
68.3% downside
Current Fair Value
68.3% downsideOvervalued by 68.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.22 Billion |
|---|---|
| Enterprise Value | $3.09 Billion |
| Dividend Yield | $0.12 (1.42%) |
| Earnings per Share | $0.41 |
| Beta | 0.48 |
| Outstanding Shares | 361,709,761 |
Return
| Return on Equity | 6.03% |
|---|---|
| Return on Assets | 4.64% |
| Return on Invested Capital | 7.83% |
Valuation & Multiples
| P/E Ratio | 22.8 |
|---|---|
| PEG | -68.27 |
| Price to Sales | 1.16 |
| Price to Book Ratio | 1.35 |
| Enterprise Value to Revenue | 1.08 |
| Enterprise Value to EBIT | 16.25 |
| Enterprise Value to Net Income | 22 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
October 29, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Baolingbao Biology Co.,Ltd.
1,505 employees
CEO: Qiang Wang Established in 1997 and headquartered in Yucheng, China, Baolingbao Biology Co.,Ltd. specializes in the production of a wide array of corn-based ingredients for health and food industries, serving both domestic and international markets....